An Evidence-Based Update on Anticholinergic Use for Drug-Induced Movement Disorders Nora Vanegas-ArroyaveStanley N. CaroffSamantha A. Cicero Current Opinion Open access 19 March 2024 Pages: 239 - 254
Current Understanding of Compulsive Sexual Behavior Disorder and Co-occurring Conditions: What Clinicians Should Know about Pharmacological Options Gemma Mestre-BachMarc N. Potenza Review Article 14 March 2024 Pages: 255 - 265
Magnetic Resonance Imaging Evidence Supporting the Efficacy of Cladribine Tablets in the Treatment of Relapsing-Remitting Multiple Sclerosis Rosa CorteseGiovanna TestaNicola De Stefano Review Article Open access 15 March 2024 Pages: 267 - 279
The Dose-Response Relationship between Opioid Agonist Therapy and Alterations in Pain Pathways in Patients with Opioid Use Disorders: A Cross-Sectional Study Kordula Lang-IllievichJohanna LangHelmar Bornemann-Cimenti Original Research Article Open access 29 February 2024 Pages: 281 - 290
SAFE-ROCK: A Phase I Trial of an Oral Application of the ROCK Inhibitor Fasudil to Assess Bioavailability, Safety, and Tolerability in Healthy Participants Andreas W. WolffJörg PeinePaul Lingor Original Research Article Open access 28 February 2024 Pages: 291 - 302
Attention-Deficit Hyperactivity Disorder (ADHD) Medication Use Trajectories Among Women in the Perinatal Period Kathrine Bang MadsenMette BliddalXiaoqin Liu Original Research Article Open access 15 March 2024 Pages: 303 - 314